within Pharmacolibrary.Drugs.ATC.V;

model V08AB10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 1.75,
    adminDuration  = 600,
    adminMass      = 0.05,
    adminCount     = 1,
    Vd             = 0.0161,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Iomeprol is a non-ionic, low-osmolar iodinated contrast medium used in diagnostic imaging procedures such as computed tomography (CT) scans and angiography to enhance the visibility of vascular structures and organs. It is approved for use in many countries for these purposes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult subjects after intravenous bolus administration.</p><h4>References</h4><ol><li>G Rosati,Clinical pharmacology of iomeprol.,European journal of radiology,1994<a href='https://pubmed.ncbi.nlm.nih.gov/8020519/'>https://pubmed.ncbi.nlm.nih.gov/8020519/</a></li><li>M Dooley, B Jarvis,Iomeprol: a review of its use as a contrast medium.,Drugs,2000<a href='https://pubmed.ncbi.nlm.nih.gov/10852647/'>https://pubmed.ncbi.nlm.nih.gov/10852647/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V08AB10;
